Literature DB >> 21124441

Cancer: Chemotherapy counteracted.

Urban Emmenegger, Robert S Kerbel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21124441     DOI： 10.1038/468637a

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  10 in total

Review 1.  Metronomic chemotherapy: new rationale for new directions.

Authors:  Eddy Pasquier; Maria Kavallaris; Nicolas André
Journal:  Nat Rev Clin Oncol       Date:  2010-06-08       Impact factor: 66.675

2.  Peering into the aftermath: The inhospitable host?

Authors:  Robert S Kerbel; John M L Ebos
Journal:  Nat Med       Date:  2010-10       Impact factor: 53.440

3.  Clinical and correlative results of SWOG S0354: a phase II trial of CNTO328 (siltuximab), a monoclonal antibody against interleukin-6, in chemotherapy-pretreated patients with castration-resistant prostate cancer.

Authors:  Tanya B Dorff; Bryan Goldman; Jacek K Pinski; Philip C Mack; Primo N Lara; Peter J Van Veldhuizen; David I Quinn; Nicholas J Vogelzang; Ian M Thompson; Maha H A Hussain
Journal:  Clin Cancer Res       Date:  2010-05-18       Impact factor: 12.531

4.  Autocrine production of interleukin-6 confers cisplatin and paclitaxel resistance in ovarian cancer cells.

Authors:  Yue Wang; Xiu Long Niu; Ye Qu; Jian Wu; Ya Qin Zhu; Wei Jia Sun; Ling Zhi Li
Journal:  Cancer Lett       Date:  2010-03-16       Impact factor: 8.679

5.  A subpopulation of CD26+ cancer stem cells with metastatic capacity in human colorectal cancer.

Authors:  Roberta Pang; Wai Lun Law; Andrew C Y Chu; Jensen T Poon; Colin S C Lam; Ariel K M Chow; Lui Ng; Leonard W H Cheung; Xiao R Lan; Hui Y Lan; Victoria P Y Tan; Thomas C Yau; Ronnie T Poon; Benjamin C Y Wong
Journal:  Cell Stem Cell       Date:  2010-06-04       Impact factor: 24.633

6.  Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion.

Authors:  Francis Rodier; Jean-Philippe Coppé; Christopher K Patil; Wieteke A M Hoeijmakers; Denise P Muñoz; Saba R Raza; Adam Freund; Eric Campeau; Albert R Davalos; Judith Campisi
Journal:  Nat Cell Biol       Date:  2009-07-13       Impact factor: 28.824

7.  DNA damage-mediated induction of a chemoresistant niche.

Authors:  Luke A Gilbert; Michael T Hemann
Journal:  Cell       Date:  2010-10-29       Impact factor: 41.582

8.  Changes in plasma levels of inflammatory cytokines in response to paclitaxel chemotherapy.

Authors:  Lajos Pusztai; Tito R Mendoza; James M Reuben; Monica M Martinez; Jie S Willey; Juanita Lara; Abdul Syed; Herbert A Fritsche; Eduardo Bruera; Daniel Booser; Vicente Valero; Banu Arun; Nuhad Ibrahim; Edgardo Rivera; Melanie Royce; Charles S Cleeland; Gabriel N Hortobagyi
Journal:  Cytokine       Date:  2004-02-07       Impact factor: 3.861

Review 9.  Instructive role of the vascular niche in promoting tumour growth and tissue repair by angiocrine factors.

Authors:  Jason M Butler; Hideki Kobayashi; Shahin Rafii
Journal:  Nat Rev Cancer       Date:  2010-02       Impact factor: 60.716

Review 10.  Cancer stem cell and niche.

Authors:  Daotai Nie
Journal:  Front Biosci (Schol Ed)       Date:  2010-01-01
  10 in total
  20 in total

1.  Anticancer agents: Unleash the forces within.

Authors:  Weiwei Gao; Liangfang Zhang
Journal:  Nat Chem       Date:  2012-12       Impact factor: 24.427

Review 2.  Unravelling the complexity of metastasis - molecular understanding and targeted therapies.

Authors:  Nilay Sethi; Yibin Kang
Journal:  Nat Rev Cancer       Date:  2011-09-23       Impact factor: 60.716

3.  Stress-inducible gene Atf3 in the noncancer host cells contributes to chemotherapy-exacerbated breast cancer metastasis.

Authors:  Yi Seok Chang; Swati P Jalgaonkar; Justin D Middleton; Tsonwin Hai
Journal:  Proc Natl Acad Sci U S A       Date:  2017-08-07       Impact factor: 11.205

4.  A Functional Iron Oxide Nanoparticles Modified with PLA-PEG-DG as Tumor-Targeted MRI Contrast Agent.

Authors:  Fei Xiong; Ke Hu; Haoli Yu; Lijun Zhou; Lina Song; Yu Zhang; Xiuhong Shan; Jianping Liu; Ning Gu
Journal:  Pharm Res       Date:  2017-06-12       Impact factor: 4.200

5.  Metabolic monosaccharides altered cell responses to anticancer drugs.

Authors:  Long Chen; Jun F Liang
Journal:  Eur J Pharm Biopharm       Date:  2012-04-02       Impact factor: 5.571

6.  Intertissue flow of glutathione (GSH) as a tumor growth-promoting mechanism: interleukin 6 induces GSH release from hepatocytes in metastatic B16 melanoma-bearing mice.

Authors:  Elena Obrador; María Benlloch; José A Pellicer; Miguel Asensi; José M Estrela
Journal:  J Biol Chem       Date:  2011-03-10       Impact factor: 5.157

Review 7.  TRPM8: a potential target for cancer treatment.

Authors:  Zhaoguo Liu; Hongyan Wu; Zhonghong Wei; Xu Wang; Peiliang Shen; Siliang Wang; Aiyun Wang; Wenxing Chen; Yin Lu
Journal:  J Cancer Res Clin Oncol       Date:  2016-01-23       Impact factor: 4.553

Review 8.  Notch signalling in cancer progression and bone metastasis.

Authors:  N Sethi; Y Kang
Journal:  Br J Cancer       Date:  2011-11-10       Impact factor: 7.640

9.  Redox/pH dual stimuli-responsive ZnO QDs-gated mesoporous silica nanoparticles as carriers in cancer therapy.

Authors:  Wanxia Wang; Youyun Wang; Yu Wang; Huameng Gong; Hongda Zhu; Mingxing Liu
Journal:  IET Nanobiotechnol       Date:  2019-08       Impact factor: 1.847

10.  Stress hormones promote growth of B16-F10 melanoma metastases: an interleukin 6- and glutathione-dependent mechanism.

Authors:  Soraya L Valles; María Benlloch; María L Rodriguez; Salvador Mena; José A Pellicer; Miguel Asensi; Elena Obrador; José M Estrela
Journal:  J Transl Med       Date:  2013-03-22       Impact factor: 5.531
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.